Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for … (NCT04182425) | Clinical Trial Compass
CompletedNot Applicable
Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis
France334 participantsStarted 2019-12-07
Plain-language summary
This study will evaluate the incidence of allergic manifestations (the first of which is atopic dermatitis) and infectious diseases in children fed with an infant formula under real conditions of use.
Who can participate
Age range5 Weeks
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* full-term infant (gestational age ≥ 37 and ≤ 42 weeks) in good health;
* Having at least one risk factor for dysbiosis, including:
* birth by caesarean section,
* Antibiotic exposure between birth and inclusion or in utero (mother who received antibiotics) during the last trimester of pregnancy, or per-partum (mother who received antibiotics during childbirth),
* a family history of allergy confirmed by a doctor in a family member, affecting at least one of the two parents or siblings (asthma, atopic dermatitis, eczema, allergic rhinitis, proven food allergy);
* Aged at most 5 weeks;
* Having a weight in the reference values for gestational age and sex (between the 10th and the 90th percentiles according to the growth curves in force);
* Already consuming an infant formula (with or without associated breast milk), or whose mother wishes to introduce an infant formula at the end of this consultation to switch to mixed breastfeeding or to start weaning;
* Authorization of a parent (or both) or legal representative of the child to collect personal information about their child and family.
Exclusion Criteria:
* Premature infants or low birth weight (\< 2500g);
* Infant allergic to cow's milk protein;
* Infants with severe congenital anomalies that may impact growth (cystic fibrosis, bronchopulmonary dysplasia, tracheomalacia, tracheoesophageal fistula, congenital heart defects ...);
* Infants with chronic disease or severe neonatal pathology, or a …
What they're measuring
1
Cumulative incidence of atopic dermatitis in the infants included in the study